Results 261 to 270 of about 38,595 (290)

SGLT2i and GLP-1RA Use in the USA

Journal of General Internal Medicine
Kyle Steiger, Rozalina G. McCoy
openaire   +1 more source

Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes

Primary Care Diabetes, 2022
Basem M Mishriky, Doyle M Cummings, James R Powell   +2 more
exaly  

GLP-1RA associated with diabetic retinopathy?

Reactions Weekly, 2019
openaire   +1 more source

Addressing Confounders in GLP‐1RA Effects on ALD Outcomes

Liver International
Chi‐Kuei Hsu, Chia‐Chih Kuo, Chih‐Cheng Lai   +2 more
openaire   +2 more sources

Bariatrische Operation versus GLP-1RA

Diabetologie und Stoffwechsel
openaire   +1 more source

GLP-1RA-related erectile dysfunction

Reactions Weekly
openaire   +1 more source

GLP-1RAs may cause intolerable gastrointestinal AEs

Reactions Weekly, 2023
openaire   +1 more source

Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population

Advances in Therapy, 2017
Hiep Nguyen
exaly  

GLP-1RA, SGLT2i und Amputationsrisiko

Diabetologie und Stoffwechsel
openaire   +1 more source

Impact of GLP ‐ 1RA on the Risk of Adverse Liver Outcomes Among Patients With Alcohol‐Associated Liver Disease and Type 2 Diabetes

Liver International
Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil   +2 more
exaly